Follow Us TR

News Details

Genprex Receives USAN Approval of Non-Proprietary Name for Lead Drug Candidate

About Genprex, Inc.
  • NASDAQ: $GNPX
  • Notified: $3.87
  • 08:17 EDT

Price Chart